Replies to post #133004 on Biotech Values

[biotech jim]

On December 12, 2011, the Company's Board of Directors expanded the size of the Board from 13 to 15 members. In addition, the Board of Directors elected Dr. Marc Tessier-Lavigne and Dr. Helen Hobbs to serve as members of the Board, effective immediately.

Helen Hobbs is in Joe Goelstein's medical genetics department at UT Southwestern and discovered the non-enzymatic activity of PCSK9 in the regulation of cholesterol levels. She also described some patients with mutant PCSK9 and the consequent protective effects on cholesterol levels.